ArticleFrontiers in cellular and infection microbiology2023

A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients.

Takahiro Tomiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.